Treatment for Bipolar
Disorder
(March 10, 2004) -- For an individual with
bipolar disorder, lifelong treatment is necessary. Regular monitoring and consultation with a health care professional is necessary to establish which
medication or
combination of medication works best.
For more than 30 years,
lithium has been the treatment of choice for people with bipolar disorder. But with the advent of newer drugs to treat the disorder over the past decade, the American Psychiatric Association (APA) issued revised treatment guidelines for the illness in April 2002.
Lithium evens out moods so that patients dont feel as high or as low, but its unclear to medical experts precisely how the medication works in the brain. Lithium is not used just for manic attacks, but rather as an ongoing treatment to prevent all types of episodes. It can take up to 14 days to start diminishing severe manic symptoms. It might take a few months of medication before the illness is under control.
When taken regularly, lithium can effectively control depression and mania and reduce the chances of recurrence. However, while it is effective treatment for many people, it doesnt work for everybody.
Regular blood tests are a must for people taking lithium. Too small a dose might not be effective and too large of one might produce
unwanted side effects, including weight gain, tremors, excessive thirst and urination, drowsiness, weakness, nausea, vomiting and fatigue.
Sodium intake also affects the amount of lithium in your body. A dramatic reduction in salt intake, excessive exercise and sweating, fever, vomiting or diarrhea may cause a lithium buildup and lead to toxicity. An overdose of lithium can cause confusion, delirium, seizures, coma and may result, although rarely, in death.
In addition to lithium, valproate (Depakote or Divalproex) is another first-line treatment for bipolar disorder. The anticonvulsants carbamazepine (Tegretol) and oxcarbazepine (Trileptal) also work as mood stabilizers. Be advised, however, that evidence suggests that valproate may lead to adverse hormone changes in teenage girls and polycystic ovary syndrome in women who began taking the medication before age 20. The data about this possible adverse effect of valproate are controversial. The problem was first noted in young women who took the medication for the treatment of epilepsy. Experts debate whether valproate causes
reproductive problems in women with epilepsy and, if so, whether women with bipolar disorder who take the medication are also at risk. In any case, young female patients taking valproate should be monitored carefully by their health care provider for possible hormonal problems and for polycystic ovary syndrome. Anticonvulsant medications may be combined with lithium, or with each other, for maximum effect.
Another anticonvulsant, lamotrigine (Lamictal), has also been shown to be effective in the treatment of bipolar disorder, especially the depressive phase. Thus, for the depressive phase of the illness, American Psychiatric Association treatment guidelines recommend either lithium or lamotrigine. Antidepressant monotherapy is not recommended. As an alternative, especially for more severely ill patients, combination treatment with lithium and an antidepressant is recommended.
Several classes of
antidepressant medications are available. These classes include tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs). Side effects and effectiveness for each class of medication, as well as for the individual brand within it, vary.
Its important to note that antidepressants can trigger mania and possibly precipitate rapid cycling. This is especially true of TCAs and MAOIs. In some cases, individuals receive treatment with antidepressants for what appears to be depression, but then become manic. Health care professionals should ask about prior symptoms of hypomania (episodes that include increased energy, euphoria, and irritability) before prescribing antidepressants. During a treatment evaluation, information about prior experiences with bipolar and other mental illnesses should be shared with a health care professional.
If a patient is experiencing psychotic or manic symptoms during an episode of bipolar disorder, sometimes physicians will also prescribe antipsychotic medicine, alone or in combination with lithium to control symptoms. Likewise, physicians might also prescribe antidepressants in addition to the lithium to counter the depressive phase.
For example,
Zyprexa (olanzapine) is an antipsychotic medicine approved by the U.S. Food and Drug Administration (FDA) that may be prescribed for the treatment of
schizophrenia and for treatment of acute mania associated with bipolar I disorder. In July 2003, the FDA approved its use in combination with lithium or valproate (Depakote or Divalproex), an anticonvulsant medication, for the treatment of acute bipolar mania. Studies have shown that bipolar patients in manic or mixed episodes treated with Zyprexa in combination therapy demonstrated improved manic and depressive symptoms, when compared to patients treated only with lithium or valproate alone.
Other helpful new drugs include the anti-psychotics aripiprazole (Abilify),
quetiapine fumarate (Seroquel), ziprasidone (Geodon) and risperidone (Risperdal). It may take up to three weeks of regular use of any medication before symptoms improve or subside. However, if no changes are apparent within six weeks, a new medication is probably necessary and options should be discussed with a health care professional.
Electroconvulsive therapy (ECT) is another treatment option for bipolar disorder and other types of
major depression. Just prior to ECT treatment, a patient is given a muscle relaxant and general anesthesia. Electrodes are then attached to the patients scalp. An electric current causes a brief convulsion. Patients do not remember the treatments and usually awake slightly confused. Acute treatments occur three times per week for two to three weeks. Maintenance ECT is also used; patients may receive treatment approximately once a month for several months.
ECT has been used for more than 60 years and has been refined since its early introduction as a treatment for depression. According to the National Mental Health Association, ECT is administered to an estimated 100,000 people a year, primarily in general hospital psychiatric units and in psychiatric hospitals. Researchers dont understand exactly how it works to improve symptoms of depression in some individuals.
Many myths and negative perceptions continue to be perpetuated about ECT. This treatment can be effective for many people with severe depression who have not responded to other forms of treatment. Some experts and patients criticize such side effects as permanent memory loss and confusion, which can occur in some people. However, the National Mental Health Association reports that 80 percent of severely depressed patients improve after being treated with ECT. Like all other treatments, you should undergo a complete physical evaluation before undergoing ECT therapy.
HealthyPlace.com
Video
Family Issues
The mentally ill are not nameless and faceless people, but
fathers, mothers, sons and daughters whose families are also
affected by the disability. Ray Guevara and his wife,
Sunshine, discuss the impact of his mental illness on their
marriage and ways they were able to cope by pulling together
as a family. Ray's mother, Mona, also offers encouraging
words for families dealing with mental illness.
watch with
windows media player.
video table of contents
here.
watch with realplayer. video table of contents
here.
|
|
|
As with all mental illnesses and other serious conditions, bipolar disorder can devastate a person's self esteem and relationships with others, especially with spouses and family. Without treatment, people with the illness may jeopardize their finances, their careers, their families and their lives. In addition to treatment with medications, psychotherapy (talk therapy) is also recommended for individuals with bipolar disorder, as well as for their family members. Consultation with and treatment by a health care professional who has experience in treating bipolar illness is recommended.
There are many treatment issues to consider for women who have bipolar disorder who
wish to become pregnant. Though manic episodes dont typically occur more often
during pregnancy for women with bipolar disorder, the postpartum period is a particularly
high-risk time for recurrence. Lithium and other types of medications, such as valproate and
carbamazepine, that are used to treat bipolar disorder can pose health risks for a developing
fetus
as well as for a breast-fed baby. As with other medications, there is particular concern
about exposing a fetus during the first trimester. Women with bipolar disorder are at high
risk for postpartum episodes, and reinstating medications near the end of the pregnancy may
prevent the onset of a postpartum episode. Therefore, adjusting medications during and
immediately after pregnancy becomes a critical strategy for
a woman with bipolar disorder
and her health care team in order to ensure the best outcome for her baby as well as for her
own mental health and stability. Preconception planning is recommended for women with bipolar
disorder, when possible, or consultation with a health care professional as early in the
pregnancy as possible, once pregnancy has occurred. New treatments with reduced risks during
pregnancy and lactation are currently under study.
top ~
next ~
send page to a
friend |